Feasibility of a Smartphone App with Mindfulness Training for Adolescent Smoking Cessation: Craving to Quit (C2Q)-Teen.
Adolescents
App delivery
Mindfulness training
Randomized controlled trial
Smoking cessation
Journal
Mindfulness
ISSN: 1868-8527
Titre abrégé: Mindfulness (N Y)
Pays: United States
ID NLM: 101518348
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
entrez:
21
12
2020
pubmed:
22
12
2020
medline:
22
12
2020
Statut:
ppublish
Résumé
The use of mobile technology for smoking cessation holds promise for adolescents, who do not typically access traditional treatments, but most are not grounded in theory or mechanism. Operant conditioning theory suggests an addictive smoking loop is formed between nicotine use and affective states, leading to habitual cue-induced craving and automatic behavior; mindfulness training may bring automated smoking behavior into awareness, so smokers may work mindfully with cravings. Mindfulness training delivered via smartphone technology therefore has potential to help adolescent smokers break this addictive loop and quit smoking. This pair-matched cluster-randomized controlled school-based pilot study evaluated program feasibility and preliminary smoking outcomes in relation to intervention engagement. Six high schools were pair matched and randomly assigned to one of three interventions: (1) mindfulness training delivered via mobile smoking cessation application (Craving to Quit, C2Q), (2) NCI's QuitSTART smoking cessation application (NCI), and (3) written cessation materials (Materials). Adolescents (n = 146) smoking 5 or more cigarettes per day were recruited. Interventions were implemented over four weeks and study assessments were collected at baseline and 3- and 6- month follow-up, including self-reported 7-day point prevalence abstinence, program usage, smoking-related measures, and psychosocial factors. Overall cotinine-validated abstinence at 6 months was 15.8% and was similar between conditions. Odds of abstinence increased with each quartile increase in app/materials use with no significant differences between conditions (OR=1.60 (C2Q), 1.66 (Materials), and 2.69 (NCI)). Of participants still smoking at 6 months, for each quartile increase in engagement the number of cigarettes smoked in the previous 7 days showed a significantly greater decline in the C2Q condition (-5.71) compared to the Materials (-0.95) and NCI (+7.73) condition (p=0.02 for differences between conditions). Cotinine-validated abstinence was similar between intervention conditions and tended to increase with greater engagement in each condition. Greater C2Q app engagement among continuing smokers was associated with a significantly greater decline in number of cigarettes smoked compared to the other conditions. The Craving to Quit (C2Q) mobile smoking cessation application with mindfulness training was feasible to use and has promise in assisting adolescents to quit or decrease cigarette smoking. Developing a Smartphone App with Mindfulness Training for Teen Smoking Cessation: ClinicalTrials.gov Identifier: NCT02218281.
Identifiants
pubmed: 33343761
doi: 10.1007/s12671-019-01273-w
pmc: PMC7747804
mid: NIHMS1547047
doi:
Banques de données
ClinicalTrials.gov
['NCT02218281']
Types de publication
Journal Article
Langues
eng
Pagination
720-733Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL150341
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001455
Pays : United States
Organisme : NIDA NIH HHS
ID : R34 DA037886
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest JB owns stock in Claritas MindSciences, the company that developed the Craving to Quit app. The other authors declare that they have no competing interest.
Références
Drug Alcohol Depend. 2009 Feb 1;100(1-2):178-81
pubmed: 19041197
Nicotine Tob Res. 2004 Feb;6(1):19-25
pubmed: 14982684
Nicotine Tob Res. 2020 Mar 16;22(3):324-331
pubmed: 29917096
JMIR Ment Health. 2015 Aug 10;2(3):e22
pubmed: 26552425
Behav Cogn Neurosci Rev. 2004 Sep;3(3):143-58
pubmed: 15653812
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Cochrane Database Syst Rev. 2017 Nov 17;11:CD003289
pubmed: 29148565
Drugs. 2002;62 Suppl 2:1-9
pubmed: 12109931
MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277
pubmed: 30439875
Trends Cogn Sci. 2005 Feb;9(2):69-74
pubmed: 15668099
MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):797-801
pubmed: 20613702
Arch Gen Psychiatry. 1982 Oct;39(10):1205-12
pubmed: 7125850
Emotion. 2006 Feb;6(1):40-61
pubmed: 16637749
Drug Alcohol Depend. 2011 Dec 1;119(1-2):72-80
pubmed: 21723049
Tob Control. 2003 Jun;12 Suppl 1:i25-34
pubmed: 12773783
Front Public Health. 2014 May 20;2:42
pubmed: 24904909
BMJ. 2004 Jun 26;328(7455):1519
pubmed: 15213107
Neuropsychopharmacology. 2019 Aug;44(9):1631-1638
pubmed: 31039580
BMC Psychiatry. 2015 Apr 14;15:83
pubmed: 25884648
Child Care Health Dev. 2003 Nov;29(6):457-64
pubmed: 14616903
Trends Cogn Sci. 2005 May;9(5):242-9
pubmed: 15866151
Transl Behav Med. 2016 Sep;6(3):410-7
pubmed: 27528530
Tob Induc Dis. 2009 Jan 30;5:3
pubmed: 19183452
Trends Cogn Sci. 2009 Aug;13(8):341-7
pubmed: 19646918
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
Nicotine Tob Res. 2004 Feb;6(1):9-17
pubmed: 14982683
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164
pubmed: 30763302
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):629-633
pubmed: 29879097
Am J Prev Med. 2013 Dec;45(6):732-6
pubmed: 24237915
BMC Complement Altern Med. 2007 Jan 25;7:2
pubmed: 17254362
JAMA Psychiatry. 2014 Oct;71(10):1103-11
pubmed: 25103718
JMIR Ment Health. 2016 May 11;3(2):e13
pubmed: 27170553
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
Neuroimage. 2012 Sep;62(3):1575-81
pubmed: 22634856
Drug Alcohol Depend. 2013 Jun 1;130(1-3):222-9
pubmed: 23265088
Am J Health Behav. 2003;27 Suppl 2:S170-84
pubmed: 14521244
Soc Cogn Affect Neurosci. 2013 Jan;8(1):73-84
pubmed: 22114078
MMWR Morb Mortal Wkly Rep. 2009 May 1;58(16):428-31
pubmed: 19407736
Tob Induc Dis. 2002 Jan 15;1(1):35-81
pubmed: 19570247
J Neurosci. 2011 Jan 19;31(3):1156-61
pubmed: 21248140
Addiction. 2000 Jun;95(6):901-13
pubmed: 10946439
Pediatrics. 2011 Nov;128(5):926-36
pubmed: 22007015
Prev Med. 2003 Sep;37(3):209-18
pubmed: 12914826
Nicotine Tob Res. 2016 May;18(5):1025-31
pubmed: 26045249
Prev Med. 2006 Oct;43(4):312-20
pubmed: 16828858